126 related articles for article (PubMed ID: 30452989)
1. Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection.
Ueno M; Nogawa M; Siddiqui R; Watashi K; Wakita T; Kato N; Ikeda M; Okimura T; Isaka S; Oda T; Ariumi Y
Int J Biol Macromol; 2019 Mar; 124():282-290. PubMed ID: 30452989
[TBL] [Abstract][Full Text] [Related]
2. Potential Antiviral Properties of Industrially Important Marine Algal Polysaccharides and Their Significance in Fighting a Future Viral Pandemic.
Geetha Bai R; Tuvikene R
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578399
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
Haraguchi Y; Takeuchi Y; Hoshino H
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activities of sulfated polysaccharides isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales).
Bouhlal R; Haslin C; Chermann JC; Colliec-Jouault S; Sinquin C; Simon G; Cerantola S; Riadi H; Bourgougnon N
Mar Drugs; 2011; 9(7):1187-1209. PubMed ID: 21822410
[TBL] [Abstract][Full Text] [Related]
5. Sulfated polysaccharides as bioactive agents from marine algae.
Ngo DH; Kim SK
Int J Biol Macromol; 2013 Nov; 62():70-5. PubMed ID: 23994790
[TBL] [Abstract][Full Text] [Related]
6. The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound.
Izumida M; Suga K; Ishibashi F; Kubo Y
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31450557
[TBL] [Abstract][Full Text] [Related]
7. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
[TBL] [Abstract][Full Text] [Related]
8. Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection.
Uryu T; Ikushima N; Katsuraya K; Shoji T; Takahashi N; Yoshida T; Kanno K; Murakami T; Nakashima H; Yamamoto N
Biochem Pharmacol; 1992 Jun; 43(11):2385-92. PubMed ID: 1351727
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses.
Hasui M; Matsuda M; Okutani K; Shigeta S
Int J Biol Macromol; 1995 Oct; 17(5):293-7. PubMed ID: 8580094
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
Opaleye OO; Igboama MC; Ojo JA; Odewale G
J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro.
Wu L; Wang W; Zhang X; Zhao X; Yu G
Carbohydr Polym; 2016 Jun; 143():139-48. PubMed ID: 27083353
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-HIV activity of sulfated cell-wall polysaccharides from gametic, carposporic and tetrasporic stages of the Mediterranean red alga Asparagopsis armata.
Haslin C; Lahaye M; Pellegrini M; Chermann JC
Planta Med; 2001 Jun; 67(4):301-5. PubMed ID: 11458443
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia.
Ramos JM; Toro C; Reyes F; Amor A; Gutiérrez F
J Clin Virol; 2011 May; 51(1):83-5. PubMed ID: 21330196
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
16. Glycans with Antiviral Activity from Marine Organisms.
Grice ID; Mariottini GL
Results Probl Cell Differ; 2018; 65():439-475. PubMed ID: 30083931
[TBL] [Abstract][Full Text] [Related]
17. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
[TBL] [Abstract][Full Text] [Related]
19. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
20. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
